PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Faron Pharmaceuticals Oy | LSE:FARN | London | Ordinary Share | FI4000153309 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 202.50 | 195.00 | 210.00 | 202.50 | 202.50 | 202.50 | 525 | 07:30:04 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 0.0 | -17.8 | -35.3 | - | 112 |
Faron Pharmaceuticals Oy (FARN) News Headlines
Faron Pharmaceuticals Oy News
| Date | Time | Source | Headline |
|---|---|---|---|
| 08/8/2022 | 07:00 | UKREG | Faron Pharmaceuticals Oy Notice of Half-Year Financial Results |
| 07/7/2022 | 09:45 | UKREG | Faron Pharmaceuticals Oy Results of EGM |
| 30/6/2022 | 17:00 | UKREG | Faron Pharmaceuticals Oy Holding(s) in Company |
| 28/6/2022 | 18:03 | ALNC |  IN BRIEF: Faron raises EUR5 million for bexmarilimab development |
| 28/6/2022 | 13:47 | UKREG | Faron Pharmaceuticals Oy Registration of New Shares |
| 28/6/2022 | 07:00 | UKREG | Faron Pharmaceuticals Oy Announcement of Placing |
| 16/6/2022 | 12:00 | UKREG | Faron Pharmaceuticals Oy Faron notice of EGM |
| 15/6/2022 | 19:24 | ALNC | IN BRIEF: Faron Pharma reveals topline results from MATINS trial |
| 15/6/2022 | 07:00 | UKREG | Faron Pharmaceuticals Oy Faron Announces Top-Line 12-Month Survival Results |
| 08/6/2022 | 16:54 | ALNC | IN BRIEF: Faron Pharma doses first patient in bexmarilimab study |
1 Year Faron Pharmaceuticals Oy Chart |
Intraday Faron Pharmaceuticals Oy Chart |
